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We investigated whether Zuonin B exerts immunological eﬀects on RAW264.7 cells. Zuonin B, isolated from ﬂower buds of
Daphne genkwa, suppressed the levels of nitric oxide and prostaglandin E2, as well as proinﬂammatory cytokines, such as tum-
or necrosis factor-α and interleukin-(IL-) 6, in lipopolysaccharide-stimulated macrophages. Moreover, the compound inhibited
cyclooxygenase-2 and inducible nitric oxide synthase expression. Zuonin B attenuated NF-kappaB (NF-κB) activation via sup-
pressing proteolysis of inhibitor kappa B-alpha (IκB-α) and p65 nuclear translocation as well as phosphorylation of extracellular
signal-regulated kinase 1/2 and c-Jun N-terminal kinase. Additionally, IL-4 and IL-13 production in ConA-induced splenocytes
was inhibited by Zuonin B. In conclusion, the anti-inﬂammatory eﬀects of Zuonin B are attributable to the suppression of pro-
inﬂammatory cytokines and mediators via blockage of NF-κB and AP-1 activation. Based on these ﬁndings, we propose that Zuo-
nin B is potentially an eﬀective functional chemical candidate for the prevention of inﬂammatory diseases.
1.Introduction
Inﬂammation is a multistep process mediated by activated
inﬂammatoryandimmunecells,includingmacrophagesand
monocytes [1], and comprises a complex series of reactions
regulated by a cascade of cytokines, growth factors, nitric
oxide (NO), and prostaglandins (PGs) produced by active
macrophages. Macrophages are key players in the immune
response to foreign invaders, such as proinﬂammatory cyto-
kines [2]. We made the highlighted change to the second
address.
NO,areactiveradicalproducedfromtheguanidinonitro-
gen of l-arginine by NO synthase (NOS), is essential for host
innate immune responses to pathogenic bacteria, viruses,
fungi, and parasites [3]. However, excessive NO production
can result in the development of inﬂammatory diseases,
including rheumatoid arthritis and autoimmune disorders
[4]. PGE2 is an inﬂammatory mediator produced during the
conversion of arachidonic acid by cyclooxygenase. In various
inﬂammatorycells,COX-2isinducedbycytokinesandother
activators, such as LPS, resulting in the release of a large
amount of PGE2 at the inﬂammatory sites [5]. Cytokines are
produced and secreted by a variety of cell types, including
macrophages and monocytes. These proteins play a major
role in the induction and regulation of cellular interactions
(e.g., inﬂammation, hematopoiesis, allergy, and immunore-
action) [6].
Nuclear transcription factor kappa-B (NF-κB) regulates
various genes involved in immune and acute phase inﬂam-
m a t o r yr e s p o n s e sa sw e l la sc e l ls u r v i v a l[ 7]. NF-κBa c t i -
vation in response to proinﬂammatory stimuli involves the
rapid phosphorylation of IκBs by the IKK signalosome com-
plex [8]. The resulting free NF-κBtranslocates to the nucleus,
where it binds to NF-κB-binding sites in the promoter2 Evidence-Based Complementary and Alternative Medicine
regions of target genes and induces the transcription of pro-
inﬂammatory mediators, such as iNOS and COX-2. In
addition to NF-κB, mitogen-activated protein kina-ses
(MAPKs) are implicated in cytokine production in macro-
phages [9]. Three MAPK families (extracellular signal-reg-
ulated kinase (ERK)1/2, p38, and c-Jun N-terminal kinase
(JNK)) are signaling molecules that react to extracellular
stimuli (mitogens) and regulate immune responses, includ-
ing proinﬂammatory cytokine production, mitosis, diﬀer-
entiation, and cell survival/apoptosis [9, 10]. A major con-
sequence of MAPK phosphorylation is activation of these
transcription factors, which serve as immediate or down-
stream substrates of the kinases [11].
In a previous study, we isolated nine lignans from the
dried ﬂower buds of Machilus thunbergii, speciﬁcally, machi-
lin A, licarin B, Zuonin B, macelignan, oleiferin C, meso-di-
hydroguaiaretic acid, licarin A, machilin F, and nectandrin
B[ 12]. The molecular mechanism and activity of Zuonin B
inmacrophagesremaintobeclariﬁed.Toestablishthemech-
anisms underlying the anti-inﬂammatory eﬀects of Zuonin
B, in the present study we investigated the expression pat-
terns of inﬂammatory mediators in LPS-stimulated RAW
264.7 cells. Additionally, we examined the eﬀects of Zuonin
B on MAPK and NF-κB activation.
2.MaterialsandMethods
2.1. Extraction and Isolation of Zuonin B. The stem bark of
M. thunbergii ( 1 . 8k g )w a st r e a t e dw i t hM e O Ha tr o o mt e m -
peraturetoproduceadarkbrownextract(290g).TheMeOH
extract was suspended in H2O, and extracted with hexane
to produce a hexane-soluble fraction (35.3g). The hexane-
soluble fraction was subjected to chromatography on a silica
gel column (500g) and eluted using a gradient of hexane
and acetone to yield four fractions. Repeated column chro-
matography of Fr. 2 (10.9g) on a silica gel (hexane/acetone;
7:3 and benzene/EtOAc; 20:1) and ODS column (MeOH,
10% aq. MeOH) aﬀorded Zuonin B(75mg). The Zuonin B
was puriﬁed as colorless needles with the following charac-
teristics: mp 49–51◦C; [α]D 0◦(c = 0.33, CHCl3); UVλmax
(CHCl3)nm(logε):294(2.45);FAB-MSm/z:363[M+Na]
+.
2.2. Cell Culture. The RAW 264.7 cell line derived from
murine macrophages was obtained from the American Type
Culture Collection (ATCC, Rockville, MD, USA). Cells were
maintained in Dulbecco’s modiﬁed Eagle’s medium supple-
mented with glutamine (1mM), 10% heat-inactivated fetal
bovine serum (FBS), penicillin (50U/mL), and streptomycin
(50μg/mL) at 37◦Ci na na t m o s p h e r eo f5 %C O 2.C e l l s
that reached a density of 5 × 104 cells/mL were activated by
incubation in medium containing E. coli LPS (1μg/mL). LPS
was added to a range of concentrations of test compounds
dissolved in DMSO. Cells treated with 0.05% DMSO were
used as the vehicle control.
2.3. MTT Assay for Cell Viability. Cells were seeded into 96-
well plates at a density of 5 × 104 cells/well, and incubated
with serum-free medium in the presence of diﬀerent con-
centrations of Zuonin B. After incubation for 24h, 10μLo f
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) (5mg/mL in saline) was added and incubation
continuedforanother4h.Mitochondrialsuccinatedehydro-
genase in live cells converts MTT to visible formazan crystals
during incubation. Formazan crystals were solubilized in
dimethylsulfoxide, and the absorbance measured at 540nm
using an enzyme-linked immunosorbent assay (ELISA)
microplate reader (Benchmark, Bio-Rad Laboratories, CA,
USA). The relative cell viability was calculated and compared
with the absorbance of the untreated control group. All ex-
periments were performed in triplicate.
2.4. Preparation and Treatment of Splenocyte Suspensions.
Spleens from BALB/c mice were removed aseptically, and a
single-cell suspension of splenocytes obtained by passing the
cellsthroughtwoneedlesinRPMI1640containing10%fetal
bovine serum, 25mM HEPES, 2mM glutamine, 100U/mL
penicillin, and 100mg/mL streptomycin (GibcoBRL, NY,
USA). Red blood cells (RBCs) were lysed with lysis buﬀer
(Sigma Chemical, St Louis, MO, USA) at 37◦C for 10min.
After washing with PBS, cells were cultured in 100ϕ dishes
for 4h. Splenocytes were plated into 96-well plates at a den-
sity of 1 × 106 cells/mL and treated with diﬀerent concen-
trations of p-hydroxycinnamic acid methyl ester for 1h, fol-
lowed by ConA (1μg/mL) for a further 3 days. The IL-4
and IL-13 levels in culture supernatants were measured
using ELISA kits for murine cytokines (R&D systems, MN,
USA), according to the manufacturer’s instructions. All ex-
perimental procedures were carried out in accordance with
the NIH Guidelines for the Care and Use of Laboratory ani-
mals, and animal handling followed the dictates of the Na-
tional Animal Welfare Law of Korea.
2.5. TNF-α and IL-6 Assays. TNF-α and IL-6 production in
RAW264.7 cells were assayed using ELISA kits (Assay design,
USA) following the manufacturer’s instructions. Cells (1 ×
106cells/well) in 96-well plates were treated with diﬀerent
concentrationsofZuoninBfor1h,productionofTNF-αand
IL-6 stimulated with 1μg/mL of LPS, and incubation con-
tinued for another 24h. The conditioned medium was used
for the subsequent experiment. Speciﬁcally, 50μLo fT N F -
α standards (prepared for calibration) or a similar volume
of Zuonin-B-treated conditioned medium was added to the
wells of TNF-α and IL-6 antibody-coated 96-well plates in
triplicate. Absorbance was determined at 450nm using the
microplate reader. Speciﬁc standard curves were employed
to quantify the amounts of TNF-α and IL-6 released by cells.
2.6. Measurement of Nitric Oxide (NO) Production. The nit-
rite concentration in culture medium was measured as an
indicatorofNOproduction,accordingtotheGriessreaction.
RAW264.7 cells (2 × 105 cells/well) were cultured in 96-well
plates using DMEM without phenol red and pretreated with
diﬀerent concentrations of Zuonin B for 1h. Cellular NO
production was induced by adding a 1μg/mL of LPS and
incubatingfor24h.Next,100μLofconditionedmediumwas
mixed with an equivalent volume of Griess reagent and incu-
bated for 15min. The absorbance of the mixture at 540nmEvidence-Based Complementary and Alternative Medicine 3
wasmeasuredwithanELISAmicroplatereader(Benchmark,
Bio-Rad Laboratories, CA, USA). The values obtained were
compared with those of standard concentrations of sodium
nitrite dissolved in DMEM, and the concentrations of nitrite
in the conditioned media of sample-treated cells calculated.
2.7. Measurement of PGE2 Levels. Production of PGE2,o n e
of the mediators released after activation of COX-2, was used
as a marker for COX-2 assessment. RAW264.7 cells (2 ×
105 cells/well) were cultured in 96-well plates with serum-
free medium and pretreated with diﬀerent concentrations of
Zuonin B for 1h. PGE2 generation (via COX-2 activation)
was stimulated by adding a 1μg/mL of LPS and incubating
for 24h. The conditioned medium was used for PGE2 deter-
mination with a prostaglandin E2 ELISA assay kit (Cayman
Chemical Co., Ann Arbor, MI, USA), according to the man-
ufacturer’s instructions. The absorbance was measured at
450nm using an enzyme-linked immunosorbent assay
(ELISA) microplate reader (Benchmark, Bio-Rad Laborato-
ries, CA, USA).
2.8. Western Blot Analysis. RAW264.7 cells exposed to Zuo-
nin B were treated with lysis buﬀer containing protease inhi-
bitors (50mM Tris-HCl (pH 7.4), 150mM NaCl, 1mM
EDTA, 0.5% NP-40, 0.1% SDS, 1mM EGTA, 100μg/mL
PMSF, 10μg/mL pepstatin A, and 100μMN a 3VO3). Homo-
genates were centrifuged at 12000g at 4◦C for 25min, and
protein concentrations in the supernatant fractions deter-
mined using Bradford reagent (Bio-Rad, Hercules, CA,
USA). Proteins were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) at 100V for
90min on 4% to 12% gradient gels. Separated proteins were
transferred to polyvinylidenediﬂuoride (PVDF) membranes
(Amersham Biosciences, Piscataway, NJ, USA). After block-
ing nonspeciﬁc binding sites with 5% nonfat dry milk dis-
solved in TBST buﬀer (10mM Tris-HCl, pH 7.5, 150mM
NaCl, 0.1% Tween-20) overnight at 4◦C, membranes were
incubatedovernightat4◦Cwithanti-iNOS,COX-2,ERK1/2,
JNK, p65, IκB-α,A P - 1 ,β-actin, and PARP antibodies. Fol-
lowing removal of the primary antibody, membranes were
washed three times with TBST buﬀer at room temperature
and subsequently incubated with horseradish-peroxidase-
(HRP-) conjugated secondary antibody for 1h at room tem-
perature. Membranes were rewashed with TBST buﬀer, and
the immunoreactive bands visualized using ECL reagent
(Amersham Pharmacia Biotech, Uppsala, Sweden).
2.9. Immunoﬂuorescence Analysis. RAW 264.7 cells cultured
on Permanox plastic chamber slides were ﬁxed with ethanol
for 30min at 4◦C. After washing with PBS and blocking with
3% bovine serum albumin in PBS for 30min, samples were
incubatedovernightat4◦Cwithrabbitpolyclonalanti-iNOS,
anti-COX-2 (1:500 dilution, Santa Cruz Biotechnology,
Santa Cruz, CA, USA), and anti-NF-κB p65 subunit (1:500
dilution,AssayDesigns)antibodies.Excessprimaryantibody
was removed, slides washed with PBS, and the samples
incubated with Texas Red-conjugated secondary antibody
(SantaCruz Biotechnology) for 2h at room temperature.
After washing, slides were mounted using ProLong Gold
Antifade reagent containing 4 ,6-diamidino-2-phenylindole
(DAPI) (Invitrogen, USA) to visualizethe nuclei. Specimens
were covered with coverslips and evaluatedunder a confocal
laserscanningmicroscope(LSM510m,CarlZeiss,Germany).
2.10. Statistical Analysis. Data were expressed as means ±
standarderrorofthemean(SEM).Statisticalsigniﬁcancewas
determined using the ANOVA test for independent means.
The critical level for signiﬁcance was set at P<0.05.
3. Results
3.1.EﬀectsofZuoninBonMacrophageToxicity. TheMTTcell
viability assay was performed using RAW264.7 cells grown in
medium to determine the eﬀects of Zuonin B (Figure 1(a)).
The cytotoxic eﬀect of Zuonin B in RAW 264.7 cells was ex-
amined to establish the appropriate concentration range for
analysis of COX-2 and iNOS expression. Neither Zuonin
Bnor DMSO exerted a signiﬁcant toxic eﬀect on RAW264.7
cells at the concentrations 3.75, 7.5, 15, and 30μM examined
after24hoftreatment(Figure 1(d)).Thus,thenontoxiccon-
centrations of Zuonin B were used for subsequent experi-
ments.
3.2. Eﬀects of Zuonin B on NO and PGE2 P r o d u c t i o ni nR A W
264.7 Cells. The eﬀects of Zuonin B on LPS-induced NO
production in RAW 264.7 cells were investigated by estimat-
ing the amount of nitrite released into the culture medium
using the Griess reaction. To ascertain whether Zuonin B
inhibits LPS-induced nitrite production and iNOS protein
expression,RAW264.7cellswerepretreatedfor1hwithvari-
ousconcentrationsofthecompoundandsubsequentlytreat-
ed with 1μg/mL LPS. No signiﬁcant diﬀerences in NO pro-
duction were observed in RAW 264.7 cells treated with Zuo-
nin B alone, compared with the negative control (data not
shown). As shown in Figure 1(b), Zuonin B suppressed nit-
rite production in a concentration-dependent manner, with
>50% inhibition at a concentration of 30μM. The COX-2
levels were examined with the PGE2 immunoassay to deter-
mine whether Zuonin B inhibition of COX-2 production is
related to modulation of PGE2 release.Notably,pretreatment
of cells with Zuonin B markedly inhibited the LPS-induced
increase in PGE2 production in a concentration-dependent
manner (Figure 1(c)).
3.3. Eﬀects of Zuonin B on iNOS and COX-2 Protein Expres-
sion in RAW 264.7 Cells. To establish the anti-inﬂammatory
activity of Zuonin B, we tested its eﬀects on LPS-induced
iNOS and COX-2 protein upregulation in RAW 264.7 cells
via Western blot and immunoﬂuorescence analyses. As
shown in Figures 2(a) and 2(c), iNOS protein expression was
notdetectedinunstimulatedcells,butwasmarkedlyincreas-
ed by 24h after stimulation with 1μg/mL LPS. Cells pre-
treated with Zuonin B displayed concentration-dependent
inhibition of iNOS protein expression following LPS stim-
ulation for 24h. As shown in Figures 2(b) and 2(c),C O X - 2
protein was detected in untreated cells, and levels increased4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Eﬀects of Zuonin B on inhibition of LPS-induced nitric oxide (NO) and prostaglandin E2 (PGE2) production in RAW264.7 cells.
Cells cultured in phenol red and serum-free media were pretreated with diﬀerent concentrations of Zuonin B for 1h and stimulated with a
1μg/mL LPS for 24h. (a) Structure of Zuonin B. (b) NO production. (c) Amount of PGE2 release. (d) Cell viability. NC: untreated control
cells; LPS: LPS only treatment. Data represent mean values of three experiments ± SEM. ∗Signiﬁcant diﬀerence from NC and #signiﬁcant
diﬀerence from LPS, P<0.05.
markedly after treatment with 1μg/mL LPS for 24h, com-
pared with the negative control (NC). Cells pretreated with
Zuonin B displayed concentration-dependent inhibition of
COX-2 protein expression following LPS stimulation for
24h.
3.4. Eﬀect of Zuonin B on NF-κB and AP-1 Translocation. We
furtherinvestigatedwhetherZuoninBpreventedthetranslo-
cation of the p65 subunit of NF-κB from the cytosol to
nucleus following release from IκB-α, leading to induction of
both iNOS and COX-2, with the aid of immunoﬂuorescence
staining. Nuclear and cytosolic extracts were subjected to
immunoblot analysis. PARP (nuclear protein) and β-actin
(cytosolic protein) were employed as controls to conﬁrm the
absence of contamination during extraction of each fraction.
Our data show that p65 is distributed in the cytoplasmic
compartment prior to LPS stimulation, but accumulates in
the nucleus after LPS treatment. The p65 and AP-1 level in
the nuclear fraction was signiﬁcantly reduced upon pretreat-
ment with Zuonin B (Figure 3(a)). As shown in Figure 3(a),
Zuonin B inhibited degradation of IκB-α as well as the LPS-
induced increase in p65 in the nuclear fraction, indicating
that the Zuonin-B-mediated suppression of IκB-α degrada-
tionprevents NF-κB-regulated expression. Immunoﬂuores-
cenceanalysesrevealedthatinunstimulatedcells,NF-κBp65
was mainly present in the cytoplasm. After LPS treatment,
the majority of intracellular p65 translocated from the cyto-
plasm to the nucleus, as evident from the strong nuclear NF-
κB p65 staining (Figure 3(b)).
3.5. Eﬀects of Zuonin B on ERK1/2 and JNK Activation. Since
the MAPK pathway is important for NF-κB activation, we
investigatedwhetherMAPKsandNF-κBareinvolvedinZuo-
nin B-induced signaling in Raw264.7 cells. MAPK activation
requires phosphorylation, detected using anti-phospho-
MAPK and anti-MAPK antibodies speciﬁc for ERK1/2 and
JNK. As shown in Figure 3(c), LPS induced phosphorylation
of ERK1/2 and JNK in nontreated cells, whereas pretreat-
ment with Zuonin B suppressed LPS-induced MAPK phos-
phorylation in a dose-dependent manner. Our results clearly
indicate that Zuonin B inhibits LPS-induced NF-κBa c t i v a -
tion via suppression of MAPK signaling.
3.6. Eﬀects of Zuonin B on TNF-α and IL-6 Production. To
conﬁrm the inhibition of proinﬂammatory cytokines, TNF-
α and IL-6 levels were additionally assessed using speciﬁc
ELISA kits. As expected, pretreatment with Zuonin Bsigniﬁ-
cantly inhibited TNF-α (Figure 4(a)) and IL-6 (Figure 4(b))
production in LPS-induced RAW264.7 cells.
3.7. Eﬀects of Zuonin B on Th2-Type Cytokines in Splenocytes.
Next,weexaminedtheeﬀectsofZuoninBontheproduction
of cytokines (IL-4 and IL-13) in splenocytes. Treatment with
ConA (1μg/mL) markedly enhanced IL-4 and IL-13 pro-
duction in splenocytes. The results showed that ConA-sti-
mulated splenocytessecretion of Th2type cytokines, such as
IL-4 (Figure 4(c))a n dI L - 1 3( Figure 4(d)), were inhibited by
Zuonin Bin a concentration-dependent manner, compared
with the controls.Evidence-Based Complementary and Alternative Medicine 5
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Figure 2: Inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression by Zuonin B. RAW264.7 cells were
pretreated with diﬀerent concentrations of Zuonin B for 1h and stimulated with LPS (1μg/mL) for a further 24h. Equal amounts of protein
in cell lysates were electrophoresed, and the protein expression levels of iNOS (a) and COX-2 (b) determined using speciﬁc antibodies for
iNOS and COX-2. The respective levels of β-actin were used to conﬁrm equal amounts of protein loading for electrophoresis. Interleukin
COX-2 and iNOS mRNA levels in lung tissue, (c) Cells were cultured for 24h with LPS (1μg/mL), ﬁxed, permeabilized, and incubated with
rabbitpolyclonalanti-iNOSandCOX-2antibody,followedbyTexas-redconjugatedanti-rabbitIg(red).Thenucleiofthecorrespondingcells
were visualized with 4 ,6-diamidino-2-phenylindole (DAPI) (magniﬁcation ×400). NC: untreated control cells; LPS: LPS only treatment.
4. Discussion
Inﬂammation is a critical factor in tumor progression. In
this study, we investigated the eﬀects of Zuonin B initially
isolated from Machilus thunbergii on LPS-induced iNOS and
COX-2 expression and its mode of action in RAW264.7
cells. Recent studies have shown that inﬂammation of these
tissues is accompanied by upregulation of the inducible NO
and iNOS isoforms [13]. The iNOS level is signiﬁcantly
correlated with the degree of inﬂammation [14]. Therefore,
inhibitory eﬀects against overproduction of NO and iNOS
may provide a measure for assessing the anti-inﬂammatory6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀects of Zuonin B on NF-κB activation and MAPK expression. (a) RAW264.7 cells were pretreated with diﬀerent concentrations
o fZ u o n i nBf o r1ha n ds t i m u l a t e dw i t hL P S( 1μg/mL) for another 1h. Equal amounts of protein in the cell lysates were electrophoresed,
and the levels of NF-κB (p65) protein in the cytosol and nucleus determined using speciﬁc antibodies for p65 and IκB-α.T h er e s p e c t i v e
protein levels of β-actin and PARP were used to conﬁrm equal amounts of protein for electrophoresis. (b) Immunoﬂuorescence staining for
NF-κB p65. RAW264.7 cells were pretreated with 30μM Zuonin B for 1h, followed by stimulation with LPS for another 1h. Cells were ﬁxed,
permeabilized, and incubated with a speciﬁc antibody for NF-κB p65, followed by Texas-red conjugated anti-rabbit Ig (red). The nuclei of
the corresponding cells were visualized by DAPI staining (magniﬁcation ×400). (c) Zuonin B inhibited LPS-stimulated phosphorylation
of ERK1/2 and JNK in Raw264.7 cells. Cells were pretreated with diﬀerent concentrations of Zuonin B for 1h, and stimulated with LPS
(1μg/mL) for another 30min. NC: untreated control cells; LPS: LPS only treatment.
eﬀects of drugs on the anti-inﬂammatory process. In our
experiments, Zuonin B inhibited NO production in a dose-
dependent manner via suppression of iNOS protein expres-
sion in LPS-stimulated RAW264.7 cells. Based on these re-
sults, we suggest that Zuonin B may eﬀectively relieve the in-
ﬂammatory pathological process associated with excessive
NO production.
PGE2 is an inﬂammatory mediator generated at inﬂam-
matory sites by COX-2, known as prostaglandin endoperox-
idesynthase, that triggers the development of several chronic
inﬂammatory diseases, such as cardiovascular disease, can-
cer,andrheumatoidarthritis[15].COX-2,aninducibleform
of cyclooxygenase, serves as an interface between inﬂamma-
tion and cancer. In response to various stimuli, including
bacterialLPS,COX-2istransientlyelevatedincertaintissues.
Abnormally elevated COX-2 causes promotion of cellular
proliferation, suppression of apoptosis, enhancement of an-
giogenesis, and invasiveness, which account for its oncogenic
function[16].Hence,PGE2 andCOX-2arebelievedtobethe
target enzymes for anti-inﬂammatory activity. In our study,
Zuonin B dose-dependently inhibited PEG2 production via
suppressing COX-2 protein expression in LPS-stimulated
RAW264.7 cells. These results indicate that Zuonin B is eﬀec-
tive in COX-2-related inﬂammatory responses.
Additionally, recent studies reveal that natural product-
sinhibit LPS-induced iNOS and COX-2 expression as well as
TNF-α release in RAW264.7 macrophages by preventing NF-
κB and MAPK activation. In our experiments, Zuonin BEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Eﬀect of Zuonin B on Th1 (TNF-α and IL-6) and Th2 (IL-4 and IL-13) type cytokine production in LPS-stimulated RAW264.7
cells and ConA-induced splenocytes. RAW264.7 cells were pretreated with diﬀerent concentrations of Zuonin B for 1h and stimulated with
LPS (1μg/mL) for another 24h. Following incubation, the amounts of TNF-α (a) and IL-6 (b) released were determined with a TNF-α
and IL-6 antibody-coated ELISA kit, as described in Section 2. Data represent the mean values of three experiments ± SEM. NC: untreated
control cells; LPS: LPS only treatment.∗Signiﬁcant diﬀerence from NC and #signiﬁcant diﬀerence from LPS: P<0.05. Con-A-stimulated
splenocytes were cultured in the presence or absence of Zuonin B. Cytokine levels were measured using ELISA. Cytokine levels, IL-4 (c) and
IL-13 (d). NC: untreated control cells; ConA, ConA (1μg/mL) only treatment. Data represent the mean values of three experiments ± SEM.
∗Signiﬁcant diﬀerence from NC and #signiﬁcant diﬀerence from ConA, P<0.05.
inhibited LPS-induced TNF-α and IL-6 production. These
ﬁndings suggest that Zuonin B exerts anti-inﬂammatory
eﬀects by inhibiting the secretion of proinﬂammatory cyto-
kines. This compound is predominantly responsible for NF-
κB activation in response to proinﬂammatory stimuli [17].
NF-κB and AP-1 are strong proinﬂammatory transcription
factors, which can regulate a variety of inﬂammatory genes,
including TNF-α [18]. NF-κB is essential for host responses
to microbial and viral infections, since the expression levels
of several inﬂammation-related genes are regulated through
the NF-κB signaling pathway [19]. Our data indicate that
Zuonin B inhibits the nuclear translocation of p65 protein
via suppressing IκB-α degradation, providing strong evi-
dence that Zuonin B inhibits NF-κB activation.
MAPKs involved in macrophage inﬂammation play im-
portant regulatory roles in cell growth and diﬀerentiation
andcontrolcellularresponsestoinﬂammatorycytokinesand
stressaswellasNF-κBacti vity[20].Moreover,MAPKsplaya
central role in inducing cytokine production and mediating
the cellular stress response [21, 22]. Several natural products
inhibit the expression of these genes by modulating MAPK
phosphorylation. In the current study, LPS induced rapid
phosphorylation of ERK1/2 and JNK in RAW264.7 cells in
theabsenceofZuoninB.However,theprecisesignalingpath-
ways among the three types of MAPKs are currently unclear.
Zuonin B also diminished IL-4 and IL-13 production in a
concentration-dependent manner in splenocytes. These re-
sults suggest that Zuonin B, at least in ConA-stimulated sple-
nocytes, exerts the anti-inﬂammatory eﬀects by suppressing
the expression of proinﬂammatory enzymes as well as the
secretion of proinﬂammatory cytokines.
In conclusion, Zuonin B exerts anti-inﬂammatory eﬀects
by suppressing intracellular NF-κB activation, which leads
to downregulation of the expression of inﬂammation-related
proteins. In view of these results, we propose that the utility
range of Zuonin B can be expanded as an anti-inﬂammatory
therapeutic agent.
Acknowledgments
This work was supported by Grants from the Ministry of
Education, Science and Technology (PDM0500839) and
KRIBB fund (KGM5231011), Republic of Korea.8 Evidence-Based Complementary and Alternative Medicine
References
[1] A. Minagar, P. Shapshak, R. Fujimura, R. Ownby, M. Heyes,
and C. Eisdorfer, “The role of macrophage/microglia and
astrocytes in the pathogenesis of three neurologic disorders:
HIV-associated dementia, Alzheimer disease, and multiple
sclerosis,” Journal of the Neurological Sciences, vol. 202, no. 1-2,
pp. 13–23, 2002.
[2] F. Berenbaum, “Proinﬂammatory cytokines, prostaglandins,
and the chondrocyte: mechanisms of intracellular activation,”
Joint Bone Spine, vol. 67, no. 6, pp. 561–564, 2000.
[3] C. F. Nathan and J. B. Hibbs Jr., “Role of nitric oxide synthesis
in macrophage antimicrobial activity,” Current Opinion in Im-
munology, vol. 3, no. 1, pp. 65–70, 1991.
[4] C. H. Evans, “Nitric oxide: what role does it play in inﬂamma-
tion and tissue destruction,” Agents and Actions Supplements,
vol. 47, pp. 107–116, 1995.
[ 5 ]W .J .Y o o n ,Y .M .H a m ,B .S .Y o o ,J .Y .M o o n ,J .K o h ,a n dC .
G. Hyun, “Oenothera laciniata inhibits lipopolysaccharide in-
ducedproductionofnitricoxide,prostaglandinE2,andproin-
ﬂammatory cytokines in RAW264.7 macrophages,” Journal of
Bioscience and Bioengineering, vol. 107, no. 4, pp. 429–438,
2009.
[6] R. A. Goldsby, T. J. Kindt, B. A. Osborne, and J. Kuby, “Im-
munology,” in Cytokines, W. H. Freeman, Ed., pp. 296–297,
W.H. Freeman, New York, NY, USA, 2005.
[7] Q. Li and I. M. Verma, “NF-κB regulation in the immune sys-
tem,” Nature Reviews Immunology, vol. 2, no. 10, pp. 725–734,
2002.
[8] M. Karin and M. Delhase, “The IκB kinase (IKK) and NF-κB:
key elements of proinﬂammatory signalling,” Seminars in Im-
munology, vol. 12, no. 1, pp. 85–98, 2000.
[9] G. Pearson, F. Robinson, T. B. Gibson et al., “Mitogen-
activated protein (MAP) kinase pathways: regulation and
physiological functions,” Endocrine Reviews, vol. 22, no. 2, pp.
153–183, 2001.
[10] S. J. Ajizian, B. K. English, and E. A. Meals, “Speciﬁc inhi-
bitors of p38 and extracellular signal-regulated kinase mito-
gen-activated protein kinase pathways block inducible nitric
oxide synthase and tumor necrosis factor accumulation in
murine macrophages stimulated with lipopolysaccharide and
interferon-γ,” Journal of Infectious Diseases, vol. 179, no. 4, pp.
939–944, 1999.
[11] K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” An-
nual Review of Immunology, vol. 21, pp. 335–376, 2003.
[12] B. Y. Park, B. S. Min, O. K. Kwon et al., “Increase of caspase-3
activity by lignans from Machilus thunbergii in HL-60 cells,”
BiologicalandPharmaceuticalBulletin,vol.27,no.8,pp.1305–
1307, 2004.
[13] T. Sawa and H. Ohshima, “Nitrative DNA damage in inﬂam-
mation and its possible role in carcinogenesis,” Nitric Oxide,
vol. 14, no. 2, pp. 91–100, 2006.
[14] H. Kimura, R. Hokari, S. Miuraet al., “Increased expression of
an inducible isoform of nitric oxide synthase and the forma-
tion of peroxynitrite in colonic mucosa of patients with active
ulcerative colitis,” Gut, vol. 42, no. 2, pp. 180–187, 1998.
[15] M. E. Turini and R. N. DuBois, “Cyclooxygenase-2: a thera-
peutic target,” Annual Review of Medicine, vol. 53, pp. 35–57,
2002.
[16] J.K.KunduandY.J.Surh,“Inﬂammation:gearingthejourney
to cancer,” Mutation Research, vol. 659, no. 1-2, pp. 15–30,
2008.
[17] H. G. Kim, D. H. Yoon, W. H. Lee et al., “Phellinus linteus
inhibits inﬂammatory mediators by suppressing redox-based
NF-κB and MAPKs activation in lipopolysaccharide-induced
RAW 264.7 macrophage,” Journal of Ethnopharmacology, vol.
114, no. 3, pp. 307–315, 2007.
[18] K. A. Roebuck, L. R. Carpenter, V. Lakshminarayanan, S. M.
Page, J. N. Moy, and L. L. Thomas, “Stimulus-speciﬁc regula-
tion of chemokine expression involves diﬀerential activation
of the redox-responsive transcription factors AP-1 and NF-
κB,” Journal of Leukocyte Biology, vol. 65, no. 3, pp. 291–298,
1999.
[19] A. Paul, S. Wilson, C. M. Belham et al., “Stress-activated pro-
tein kinases: activation, regulation and function,” Cellular Sig-
nalling, vol. 9, no. 6, pp. 403–410, 1997.
[20] Y. J. Surh, K. S. Chun, H. H. Cha et al., “Molecular mecha-
nisms underlying chemopreventive activities of anti-inﬂam-
matoryphytochemicals:down-regulationofCOX-2andiNOS
through suppression of NF-κB activation,” Mutation Research,
vol. 480-481, pp. 243–268, 2001.
[21] K. M. K. Rao, “MAP kinase activation in macrophages,” Jour-
nal of Leukocyte Biology, vol. 69, no. 1, pp. 3–10, 2001.
[22] J.X.Jiang,Y.Zhang,S.H.Ji,P.Zhu,andZ.G.Wang,“Kinetics
of mitogen-activated protein kinase family in lipopolysacch-
aride-stimulatedmouseKupﬀercellsandtheirroleincytokine
production,” Shock, vol. 18, no. 4, pp. 336–341, 2002.